The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 2, 2012, Pages 344-353

  Fuchs, Martin ^a   Briel, Matthias ^b,c   Daikeler, Thomas ^a   Walker, Ulrich A ^m   Rasch, Helmut ^a   Berg, Scott ^a   Ng, Quinn K T ^a   Raatz, Heike ^b   Jayne, David ^d   Kötter, Ina ^e   Blockmans, Daniel ^f   Cid, Maria C ^g   Prieto González, Sergio ^g   Lamprecht, Peter ^h   Salvarani, Carlo ⁱ   Karageorgaki, Zaharenia ^j   Watts, Richard ^k,n   Luqmani, Raashid ^l   Müller Brand, Jan ^a   Tyndall, Alan ^a   Walter, Martin A ^a   more..

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c MCMASTER UNIVERSITY   (Canada)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ Arcispedale S Maria Nuova ^*  (Italy)

^j Agios Dimitrios General Hospital   (Greece)

^k UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^l NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^m UNIVERSITY OF BASEL   (Switzerland)

ⁿ IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

more..

Author keywords

Fluorodeoxyglucose; Giant cell arteritis; Immunosuppressive drugs; Positron emission tomography; Takayasu's arteritis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUORODEOXYGLUCOSE F 18; GLUCOCORTICOID; METHOTREXATE; IMMUNOSUPPRESSIVE AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AORTA ARCH SYNDROME; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GIANT CELL ARTERITIS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; ADOLESCENT; ARTERITIS; CASE CONTROL STUDY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; REPRODUCIBILITY; RHEUMATOLOGY; SCINTISCANNING; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERITIS; CASE-CONTROL STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY; TAKAYASU ARTERITIS; VASCULITIS;

EID: 84859628890     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1967-x     Document Type: Article

References (31)

1. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008;372:234-45. (Pubitemid 351997438)
2. Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010;69:1744-50.
3. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009;68:318-23.
4. Salvarani C, Silingardi M, Ghirarduzzi A, Lo Scocco G, Macchioni P, Bajocchi G, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med 2002;137:232-8.
5. Blockmans D. Utility of imaging studies in assessment of vascular inflammation. Cleve Clin J Med 2002;69 Suppl 2:SII95-9. (Pubitemid 41315563)
6. Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002;46:1634-42. (Pubitemid 34620212)
7. Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 2004;16:31-7. (Pubitemid 38041396)
8. Seo P, Stone JH. Large-vessel vasculitis. Arthritis Rheum 2004;51:128-39. (Pubitemid 38222293)
9. Aschwanden M, Kesten F, Stern M, Thalhammer C, Walker UA, Tyndall A, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis 2010;69:1356-9.
10. Weber WA, Grosu AL, Czernin J. Technology insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nat Clin Pract Oncol 2008;5:160-70.
11. Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002;43:658-63. (Pubitemid 34507119)
12. Jones HA, Cadwallader KA, White JF, Uddin M, Peters AM, Chilvers ER. Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: implications for interpretation of (18)F-FDG PET images. J Nucl Med 2002;43:652-7. (Pubitemid 34507118)
13. Turlakow A, Yeung HW, Pui J, Macapinlac H, Liebovitz E, Rusch V, et al. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 2001;161:1003-7. (Pubitemid 32295655)
14. Brodmann M, Lipp RW, Aigner R, Pilger E. Positron emission tomography reveals extended thoracic and abdominal peri-aortitis. Vasc Med 2003;8:127-8. (Pubitemid 37168254)
15. Hara M, Goodman PC, Leder RA. FDG-PET finding in earlyphase Takayasu arteritis. J Comput Assist Tomogr 1999;23:16-8. (Pubitemid 29095460)
16. Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999;38:444-7. (Pubitemid 29507129)
17. Meller J, Grabbe E, Becker W, Vosshenrich R. Value of F-18 FDG hybrid camera PET and MRI in early takayasu aortitis. Eur Radiol 2003;13:400-5. (Pubitemid 36798619)
18. Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006;55:131-7. (Pubitemid 43235138)
19. Meller J, Strutz F, Siefker U, Scheel A, Sahlmann CO, Lehmann K, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003;30:730-6. (Pubitemid 36612957)
20. Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005;32:674-81. (Pubitemid 40897490)
21. Webb M, Chambers A, AL-Nahhas A,Mason JC,Maudlin L, Rahman L, et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004;31:627-34. (Pubitemid 38647900)
22. Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol 2009;21:19-28.
23. Henes JC, Müller M, Krieger J, Balletshofer B, Pfannenberg AC, Kanz L, et al. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 2008;26:S47-52.
24. Walter MA. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin North Am 2007;45:735-44. viii. (Pubitemid 47238397)
25. Scheel AK, Meller J, Vosshenrich R, Kohlhoff E, Siefker U, Müller GA, et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 2004;63:1507-10. (Pubitemid 39433961)
26. Blockmans D, Coudyzer W, Vanderschueren S, Stroobants S, Loeckx D, Heye S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 2008;47:1179-84. (Pubitemid 352038223)
27. Spira D, Kötter I, Ernemann U, Balletshofer B, Pfannenberg CA, Fenchel M, et al. Imaging of primary and secondary inflammatory diseases involving large and medium-sized vessels and their potential mimics: a multitechnique approach. AJR Am J Roentgenol 2010;194:848-56.
28. Bleeker-Rovers CP, Bredie SJ, van der Meer JW, Corstens FH, Oyen WJ. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 2004;116:50-3. (Pubitemid 38050027)
29. Iwabu M, Yamamoto Y, Dobashi H, Kameda T, Kittaka K, Nishiyama Y. F-18 FDG PET findings of Takayasu arteritis before and after immunosuppressive therapy. Clin Nucl Med 2008;33:872-3.
30. Miller MD, Ferris DG. Measurement of subjective phenomena in primary care research: the Visual Analogue Scale. Fam Pract Res J 1993;13:15-24.
31. Brodmann M, Lipp RW, Passath A, Seinost G, Pabst E, Pilger E. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 2004;43:241-2. (Pubitemid 38219684)